References
- McCullough MJ, Clemons KV, McCusker JH, Stevens DA. Species identification and virulence attributes of Saccha-romyces boulardii (nom. inval.). J Clin Microbiol 1998; 36: 2613–7.
- McFarland LV, Bernasconi P. Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microb Ecol Health Dis 1993; 6: 157–71.
- Fuller R. Probiotics in human medicine. Gut 1991; 32: 439–42.
- Roffe Ch. Biotherapy for antibiotic-associated and other di-arrhoeas. J Infection 1996; 32: 1–10.
- Tang P, Foubister V, Pucciarelli MG, Finlay BB. Methods to study bacterial invasion. J Microbiol Meth 1993; 18: 227–40.
- Isberg RR. Discrimination between intracellular uptake and surface adhesion of bacterial pathogens. Science 1991; 252: 934–8.
- Galan J E, Curtiss III R. Cloning and molecular characteri-zation of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci USA 1989; 86: 6383–7.
- Tood ECD. Preliminary estimates of costs of food borne disease in Canada/United States and costs to reduce Salmonellosis. J Food Protect 1989; 52: 586–601.
- Schnack J. In-vitro Interaktionen zwischen Saccharomyces boulardii und Toxinen von enteropathogenen Bakterien. 1994. Master of Science Thesis, University of Zurich, Switzerland.
- Altwegg M, Schnack J, Zbinden R. Influence of Saccha-romyces boulardii on Aeromonas hemolysin. Med Microbiol Lett 1995; 4: 417–25.